Periodically NF2 BioSolutions organizes webinars around topics relevant to NF2 with the help of world-renowned experts. Your contributions helps continue with this fight, please consider donating to further Gene Therapy by using the button below.
This webinar will cover the limited treatment options available for individuals with NF2-SWN and the need for novel therapeutic targets. The speaker will discuss their research on the immunological pathways of NF2-SWN tumors using innovative imaging techniques and how immunotherapies may reduce tumor growth in patients. The goal is to provide insight into potential new treatments for the improvement of NF2-SWN patient lives.
We held a webinar on the topic of “NF2 Drug Development Update: Bacteria-Mediated Immunotherapy”. It took place virtually on Saturday, January 14th, 2023 at 11:00 am ET over Zoom.
NF2 BioSolutions funded the preclinical research of Dr. Brenner and Dr. Mekalanos and it led to the creation of the biotech Mulberry Biotherapeutics. NF2 BioSolutions is supporting MulberryBio to make sure they will succeed in establishing a clinical trial and developing a drug for NF2 patients and patients suffering from sporadic Schwannomas.
On Tuesday, November 29th we are fundraising to benefit Dr. Jianbing Zhou’s project at Yale. We hope to reach the goal of $100,000 in order to jumpstart a new project in this lab. Don’t miss out on our Giving Tuesday webinar where we will go over updates on the research initiatives we are supporting plus Dr. Zhou’s new project! Register here.
Monday 28th of February is Rare Disease Day, and NF2 Biosolutions will raise funds to sponsor a new approach for tackling Neurofibromatosis type 2. This approach is called Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes, it is a type of novel immunotherapy that has been used and it’s effective in other cancers. On Monday we will also hold a webinar where Dr. Claire O’Leary will explain the objective of this project and how immunotherapy could be the answer to NF2 mutations.
We are delighted to present our first ever NF2 showcase webinar in partnership with One Nucleus on air on Friday, February 4th, 2022 at 12noon (GMT).
NF2 BioSolutions UK CEO Clare Goddard and One Nucleus CEO Tony Jones present and invite you to our showcase featuring charity trustee and world-renowned NF2 expert Prof. Gareth Evans. Then listen to our 2 NF2 Ph.D. researchers Grace and Adam on their NF2 tumour inflammation work, followed by major fundraiser Andy White and his motivation for raising funds and awareness to help end NF2.
Crispr/Cas9-based gene editing to achieve such repair in Schwann cells bearing three distinct types of NF2 mutations (large deletion, small deletion, point mutation) that are encountered in patients.
Learn about the importance of donating your tissue from surgery to the NF2 BioBank and how it can benefit ALL of us!
When: Oct 24, 2020 11:00 AM Eastern time (the US and Canada) – 16:00 London time
We will hear from Dr. John Mekalanos from Harvard Medical School and Dr. Gary Brenner from Massachusetts General Hospital about how their labs are working with genetically modified bacteria to kill NF2 tumor cells and how you can support this exciting new project!
For our first-ever NF2 gene therapy webinar! Chief Scientific Officer Dr. Edgar Rodríguez-Lebrón presents Gene Therapy 101 to give us a better understanding of how gene therapy works and what types of therapies are most promising for curing NF2. You will not want to miss this!